ImmunityBio, Inc. Logo

ImmunityBio, Inc.

Develops immunotherapies activating the immune system to fight cancer and infectious diseases.

IBRX | NDAQ

Overview

Corporate Details

ISIN(s):
US45256X1037
LEI:
Country:
United States of America
Address:
3530 JOHN HOPKINS COURT, 92121 SAN DIEGO
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

ImmunityBio, Inc. is a commercial-stage biotechnology company developing next-generation immunotherapies for cancers and infectious diseases. The company's core strategy is to strengthen the patient's own immune system by activating both its innate and adaptive branches, a comprehensive approach designed to orchestrate a coordinated attack on diseased cells and establish long-term immunological memory. Its clinical pipeline features therapies such as the IL-15 superagonist ANKTIVA®, engineered natural killer (NK) cell platforms, and adenovirus-vectored vaccines. These investigational treatments target a range of conditions, including various solid tumors like bladder and lung cancer, as well as infectious diseases such as HIV. ImmunityBio also provides its NK-92® cell line as a bioanalytical tool for research scientists.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ImmunityBio, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ImmunityBio, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ImmunityBio, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
AMARIN CORP PLC\UK Logo
Develops prescription therapies like Vascepa® to reduce cardiovascular risk for patients.
United States of America AMRN
AMGEN INC Logo
Biotech pioneer developing innovative human therapeutics for the world's toughest diseases.
United States of America AMGN
Biotech firm using enzyme tech for pharma, healthcare, and bioprocess CDMO services.
South Korea 092040
AMICUS THERAPEUTICS, INC. Logo
Develops advanced therapies for rare lysosomal storage disorders.
United States of America FOLD
AMINOLOGICS CO.,LTD. Logo
Manufactures high-purity chiral amino acids & APIs for pharma, chemical, and food industries.
South Korea 074430
Amneal Pharmaceuticals, Inc. Logo
Develops & commercializes essential medicines: generics, injectables & specialty drugs.
United States of America AMRX
Amphastar Pharmaceuticals, Inc. Logo
Develops and manufactures complex injectable, intranasal, and inhalation pharmaceutical products.
United States of America AMPH
Amylyx Pharmaceuticals, Inc. Logo
Developing novel therapies for neurodegenerative diseases like ALS and Wolfram syndrome.
United States of America AMLX
AN2 Therapeutics, Inc. Logo
Developing novel small molecule drugs for infectious diseases and oncology using boron chemistry.
United States of America ANTX
Develops approved cannabinoid medicines for pain, epilepsy, and heart failure.
United Kingdom ANAN

Talk to a Data Expert

Have a question? We'll get back to you promptly.